Menu

Speaking of Science

November 2014's selection of notable quotes

Nov 1, 2014
The Scientist Staff

TECHNICOLOR CONNECTIONS: Diffusion tensor imaging imbues axonal nerve fibers in the brain with a profusion of color. JG MARCELINO/WEBS R US/WIKIMEDIA COMMONS

Your connectome is you. If you know all 1015 connections in your brain, and you understand those, [it is possible to predict] exactly what you are going to do.

—University of Virginia neuroscientist Barry Condron, opining on the promise of neuroscience research (The Cavalier Daily, October 10)

 

What we’re discovering about the brain through spatial mapping is likely of greater consequence than just for understanding about space. . . . Indeed, it seems to support autobiographical memory in humans.

Colin Lever, a senior lecturer in the department of psychology at Durham University in the U.K., speaking to The Scientist about the Nobel Prize recently awarded to his mentor John O’Keefe and to May-Britt and Edvard Moser for discovering cells that constitute the brain’s GPS system (October 6)

 

I am much better at recognizing my neighbors’ dogs (they have characteristic shapes and colors) than my neighbors themselves.

—Neurologist and author Oliver Sacks, in his 2010 book The Mind’s Eye, in which he discusses his struggles with prosopagnosia, or face blindness

 

Sex is a critical variable when trying to understand the biological and behavioral systems that fundamentally shape human health. As such, it also is a critical element to be considered when designing rigorous preclinical research experiments that inform human studies.

Sally Rockey, the National Institutes of Health’s Deputy Director for Extramural Research, on the agency’s plan to develop and implement policies requiring NIH applicants to consider sex as a variable in biomedical research involving animals and cells (September 11)

 

During the current emergency, caring for the sick and stopping the spread of the virus are clearly the most important and immediate tasks. Once the epidemic is over, however, it will be paramount to reassess the extent of the area at risk of outbreaks. Health care systems in these regions will then need to be strengthened and made capable of curbing any further outbreaks at the source. The area found to be at risk is home to some of the most under-resourced health care systems in the world—with the five countries afflicted by the current outbreak ranking among the world’s worst both in terms of maternal mortality and human development.

Sebastian Funk, researcher at the Centre for the Mathematical Modelling of Infectious Diseases, and Peter Piot, London School of Hygiene and Tropical Medicine microbiologist and codiscoverer of the Ebola virus, in a recent eLife paper about mapping the disease in wild African animals (September 19)

 

I have Ebola. You’re all screwed. 

—The ill-advised, post-sneeze joke voiced by an as-yet-unnamed man who was escorted off of his flight by health workers wearing full hazmat suits in Punta Cana, Dominican Republic (October 10)

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.